What does this TikTok actually claim?
The video encourages viewers to take before and after photos when starting GLP-1 medications like tirzepatide and semaglutide. Creator Court positions herself as a "GLP bestie" and frames photo documentation as essential for tracking weight loss progress.
While the video itself is brief, the hashtags tie it to broader claims about hormone balancing and weight loss journeys. This reflects a common pattern where GLP-1 content creators position these diabetes medications as comprehensive wellness solutions.
Is photo documentation actually helpful for GLP-1 users?
Yes, progress photos can be valuable for people using semaglutide or tirzepatide. These medications work slowly, with peak effects often taking 16-20 weeks at maintenance doses.
The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% weight loss with 2.4mg semaglutide over 68 weeks. That's gradual change that might not feel dramatic day-to-day. Photos can help users recognize real progress when the scale stalls or fluctuates.
However, photos shouldn't replace medical monitoring. Regular check-ins with healthcare providers matter more than social media documentation, especially given potential side effects like nausea, gastroparesis, and muscle loss.
What's misleading about the "hormone balancing" angle?
The hashtag #hormonebalancing oversells what GLP-1 medications actually do. Semaglutide and tirzepatide target specific receptors to slow gastric emptying and reduce appetite. They're not broad hormone regulators.
The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found 20.9% weight loss with 15mg tirzepatide over 72 weeks. This happened through appetite suppression and delayed stomach emptying, not by "balancing hormones" generally.
While weight loss can improve insulin sensitivity and other metabolic markers, calling these drugs hormone balancers is like calling a wrench a universal tool. It's technically not wrong, but it misses the point of how they actually work.
Should you trust GLP-1 influencers for medical advice?
Probably not as your primary source. Court's advice about photos is harmless, but her "GLP bestie" branding suggests a casual relationship with serious medications that require medical supervision.
Real clinical trials involve careful dose escalation, starting with 0.25mg semaglutide weekly and increasing slowly to minimize side effects. The STEP trials excluded people with certain medical conditions and monitored participants closely.
Social media creators can share experiences, but they can't replicate the individualized medical oversight that made the clinical trials successful. Your actual doctor beats your GLP bestie every time.
What should people actually know about progress tracking?
Photos work, but they're just one tool. The clinical trials measured success through multiple metrics including weight, waist circumference, blood pressure, and HbA1c levels.
Expect slow progress. In STEP 1, participants lost an average of 1.7 pounds per month over 68 weeks. That's not Instagram-ready transformation speed, but it's sustainable change backed by rigorous research.
Don't let social media pressure drive unrealistic expectations. The most successful trial participants combined medication with lifestyle counseling and regular medical monitoring, not just before-and-after photo shoots.